MedPath

ENERGENESIS BIOMEDICAL CO., LTD.

ENERGENESIS BIOMEDICAL CO., LTD. logo
🇹🇼Taiwan
Ownership
Public
Established
2012-01-01
Employees
11
Market Cap
-
Website
http://www.energenesis-biomedical.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:3
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (75.0%)
Phase 3
1 (25.0%)

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Phase 3
Recruiting
Conditions
Diabetic Foot Ulcer
Foot Ulcer
Diabetes Mellitus
Wound
Interventions
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle
First Posted Date
2023-07-05
Last Posted Date
2024-12-09
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
230
Registration Number
NCT05930210
Locations
🇨🇳

Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan

🇨🇳

Kung Tien General Hospital, Taichung, Taiwan

🇨🇳

Chi Mei Medical Center, Tainan, Taiwan

and more 21 locations

A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

Phase 2
Recruiting
Conditions
Venous Leg Ulcer
Interventions
Drug: ENERGI-F703 GEL matched vehicle
Drug: ENERGI-F703 GEL
First Posted Date
2019-09-06
Last Posted Date
2024-02-20
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
80
Registration Number
NCT04078555
Locations
🇨🇳

Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

ENERGI-F701 for Female Hair Loss Treatment

Phase 2
Completed
Conditions
Hair Loss
Female Pattern Baldness
Alopecia
Interventions
First Posted Date
2017-11-22
Last Posted Date
2020-11-24
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
67
Registration Number
NCT03351322
Locations
🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

Phase 2
Completed
Conditions
Diabetic Foot
Foot Ulcer
Diabetes Mellitus
Wounds
Interventions
Drug: ENERGI-F703 matched vehicle
First Posted Date
2016-02-03
Last Posted Date
2020-11-24
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Target Recruit Count
141
Registration Number
NCT02672436
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.